Form 8-K - Current report:
SEC Accession No. 0000805928-25-000006
Filing Date
2025-01-10
Accepted
2025-01-10 08:01:57
Documents
17
Period of Report
2025-01-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K axgn-20250110.htm   iXBRL 8-K 27153
2 EX-99.1 axogenincpressreleasedat.htm EX-99.1 9435
6 axogenincpressreleasedat001.jpg GRAPHIC 234766
7 axogenincpressreleasedat002.jpg GRAPHIC 341106
8 axogenincpressreleasedat003.jpg GRAPHIC 81888
  Complete submission text file 0000805928-25-000006.txt   1070879

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT axgn-20250110.xsd EX-101.SCH 1788
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT axgn-20250110_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT axgn-20250110_pre.xml EX-101.PRE 12512
19 EXTRACTED XBRL INSTANCE DOCUMENT axgn-20250110_htm.xml XML 2709
Mailing Address 13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615
Business Address 13631 PROGRESS BLVD. SUITE 400 ALACHUA FL 32615 (386) 462-6817
Axogen, Inc. (Filer) CIK: 0000805928 (see all company filings)

EIN.: 411301878 | State of Incorp.: MN | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36046 | Film No.: 25520510
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)